Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 683 results found. Search for [ Ranbaxy ]

Results 1 to 21 of 683
BusinessToday.in
February 19, 2018
The corporate affairs ministry has been looking into the affairs of Fortis Healthcare and Religare Enterprises after recent reports that financial irregularities have emerged at the two companies


www.businesstoday.in
February 14, 2018



BusinessToday.in
New Delhi, February 13, 2018
Fortis says that apart from paying Rs 65.98 lakh fine to stock exchanges for \"non-submission of un-audited financial results\", the reports emerging in the media had \"enhanced the scope of limited review audit by the statutory auditors\".


BusinessToday.in
New Delhi, February 9, 2018
The duo quit as directors from the company's board on Thursday. The company issued a release saying the resignation is \"intended to free the organisation from any encumbrances that may be linked to the promoters in light of the recent HC judgement.\"


BusinessToday.in
February 9, 2018
Days after the Delhi High Court verdict dealt a body blow to Fortis Healthcare promoters - Malvinder Mohan Singh and Shivinder Mohan Singh - by upholding the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo, the duo have quit as directors from the company's board


BusinessToday.in
February 9, 2018
At 12:29 pm, the stock was trading 12.09% or 15.25 points higher at 141.35 level in an otherwise falling market. The stock hit an intra day high of 157.05 level and a low of 123.10 level. It is down 11.53% since the beginning of this year. On  an yearly basis, the stock has fallen 28.71% on BSE.


www.businesstoday.in
February 8, 2018



BT Guest Columnist
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.


www.businesstoday.in
January 31, 2018



BusinessToday.in
New Delhi, February 8, 2018
Fortis Healthcare promoters Malvinder Mohan Singh and Shivinder Mohan Singh, also called Singh Brothers, on Thursday resigned as directors from the company's board days after the Delhi High Court order upheld the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo.


www.businesstoday.in
January 30, 2018



www.businesstoday.in
January 5, 2018



E Kumar Sharma
New Delhi, December 28, 2017
 The just concluded year, hurt Indian pharma companies in more ways than one


PB Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


BusinessToday.in
November 21, 2017
Ahmedabad-based Eris Lifesciences' acquisition of the India brand business of Bengaluru-based Strides Shasun has been in the news.


BusinessToday.in
New Delhi, November 14, 2017
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal.


PB Jayakumar
November 6, 2017
The Rs 3600 crore acquisition of Unichem's domestic business by Torrent Pharma has brought the mojo back into India pharma's merger and acquisition scene, which was eluding large deals in the past few years.


Mail Today Bureau
November 4, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.


Mail Today Bureau
November 4, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.


PTI
New Delhi, November 3, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it.


PAGES 1 OF 35  12345